Dai F, Wengler K, He X, Wang J, Yang J, Parsey R
Transl Psychiatry. 2025; 15(1):71.
PMID: 40025010
PMC: 11873289.
DOI: 10.1038/s41398-025-03292-9.
Li H, Gao J, Song H, Yang X, Li C, Zhang Y
CNS Neurosci Ther. 2024; 30(9):e70048.
PMID: 39300492
PMC: 11412791.
DOI: 10.1111/cns.70048.
Tan J, Zhang G, Hao J, Cai H, Wu D, Su Z
Psychoradiology. 2024; 3:kkad020.
PMID: 38666107
PMC: 10917387.
DOI: 10.1093/psyrad/kkad020.
Liu H, Wang C, Lan X, Li W, Zhang F, Hu Z
Eur Psychiatry. 2024; 67(1):e33.
PMID: 38572583
PMC: 11059247.
DOI: 10.1192/j.eurpsy.2024.1744.
Ng T, Sarikahya M, Hudson R, Szkudlarek H, Perez-Valenzuela E, Uzuneser T
Neuropsychopharmacology. 2024; 49(7):1171-1182.
PMID: 38521861
PMC: 11109238.
DOI: 10.1038/s41386-024-01853-y.
Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in Parkinson's Disease-A Narrative Review.
Chmiel J, Rybakowski F, Leszek J
J Clin Med. 2024; 13(3).
PMID: 38337395
PMC: 10856764.
DOI: 10.3390/jcm13030699.
Cortical glutamate, Glx, and total N-acetylaspartate: potential biomarkers of repetitive transcranial magnetic stimulation treatment response and outcomes in major depression.
Gonsalves M, White T, Barredo J, DeMayo M, DeLuca E, Harris A
Transl Psychiatry. 2024; 14(1):5.
PMID: 38184652
PMC: 10771455.
DOI: 10.1038/s41398-023-02715-9.
Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut-Brain Axis.
Liwinski T, Lang U, Bruhl A, Schneider E
Biomedicines. 2023; 11(12).
PMID: 38137351
PMC: 10741010.
DOI: 10.3390/biomedicines11123128.
Prefrontal photobiomodulation produces beneficial mitochondrial and oxygenation effects in older adults with bipolar disorder.
ODonnell C, Barrett D, OConnor P, Gonzalez-Lima F
Front Neurosci. 2023; 17:1268955.
PMID: 38027522
PMC: 10644301.
DOI: 10.3389/fnins.2023.1268955.
Neurobiological mechanisms of ECT and TMS treatment in depression: study protocol of a multimodal magnetic resonance investigation.
Frid L, Kessler U, Ousdal O, Hammar A, Haavik J, Riemer F
BMC Psychiatry. 2023; 23(1):791.
PMID: 37904091
PMC: 10617235.
DOI: 10.1186/s12888-023-05239-0.
Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.
Yang Y, Smucny J, Zhang H, Maddock R
Neuroimage Clin. 2023; 39:103461.
PMID: 37406595
PMC: 10509531.
DOI: 10.1016/j.nicl.2023.103461.
Electroconvulsive therapy triggers a reversible decrease in brain N-acetylaspartate.
Erchinger V, Craven A, Ersland L, Oedegaard K, Bartz-Johannessen C, Hammar A
Front Psychiatry. 2023; 14:1155689.
PMID: 37363174
PMC: 10289547.
DOI: 10.3389/fpsyt.2023.1155689.
Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
Holmes S, Asch R, Davis M, DellaGioia N, Pashankar N, Gallezot J
Biol Psychiatry. 2023; 93(12):1099-1107.
PMID: 36764853
PMC: 10164841.
DOI: 10.1016/j.biopsych.2022.10.018.
Glutamatergic and N-Acetylaspartate Metabolites in Bipolar Disorder: A Systematic Review and Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies.
Chabert J, Allauze E, Pereira B, Chassain C, De Chazeron I, Rotge J
Int J Mol Sci. 2022; 23(16).
PMID: 36012234
PMC: 9409038.
DOI: 10.3390/ijms23168974.
A pilot spectroscopy study of adversity in adolescents.
Sonmez A, Lewis C, Port J, Athreya A, Choi D, Zaccariello M
Biomark Neuropsychiatry. 2022; 5.
PMID: 35783196
PMC: 9248870.
DOI: 10.1016/j.bionps.2021.100043.
Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis.
Murphy F, Nasa A, Cullinane D, Raajakesary K, Gazzaz A, Sooknarine V
Front Psychiatry. 2022; 13:748372.
PMID: 35599780
PMC: 9120425.
DOI: 10.3389/fpsyt.2022.748372.
Continuous Ingestion of JB-1 during Chronic Stress Ensures Neurometabolic and Behavioural Stability in Rats.
Chudzik A, Slowik T, Kochalska K, Pankowska A, Lazorczyk A, Andres-Mach M
Int J Mol Sci. 2022; 23(9).
PMID: 35563564
PMC: 9106030.
DOI: 10.3390/ijms23095173.
Glutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization.
Khoodoruth M, Estudillo-Guerra M, Pacheco-Barrios K, Nyundo A, Chapa-Koloffon G, Ouanes S
Front Psychiatry. 2022; 13:886918.
PMID: 35492692
PMC: 9047946.
DOI: 10.3389/fpsyt.2022.886918.
Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review.
Marshall R, Droste J, Giessing J, Kreider R
Nutrients. 2022; 14(3).
PMID: 35276888
PMC: 8838971.
DOI: 10.3390/nu14030529.
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status.
Henter I, Park L, Zarate Jr C
CNS Drugs. 2021; 35(5):527-543.
PMID: 33904154
PMC: 8201267.
DOI: 10.1007/s40263-021-00816-x.